文献速递重症综合管理与镇静镇痛

基因关联研究中的质量控制措施与验证:对急性疾病的启示

Quality Control Measures and Validation in Gene Association Studies: Lessons for Acute Illness.
PubMed 文献 · Shock · 2020-01-01
一句话结论综述指出,急性疾病SNP关联研究的临床价值取决于是否遵循质控方案、纳入足够患者及用独立技术验证。

该综述聚焦急性疾病(如创伤和脓毒症)中单核苷酸多态性(SNP)与临床及药物结局的关联研究。作者于2018年12月和2019年1月检索2011年1月至2019年2月发表的同行评议文献,以创伤和脓毒症研究为例,审视关键方法与结果。综述发现三点可提高SNP关联研究潜在准确性的要点:提供遵循质控方案的证据、纳入足够患者形成大队列、用独立技术验证SNP。作者认为需要标准化验证方法和SNP质控措施。

要点

  • 综述提出提高SNP关联研究准确性的三点:提供遵循如Nature Protocols或OncoArray QC Guidelines等质控方案的证据。
  • 第二点为纳入足够患者以形成大队列组。
  • 第三点为用独立技术验证SNP,如用相同SNP在新患者队列中开展第二项研究。
  • 作者认为需在医学领域、尤其是急性疾病等复杂疾病状态下标准化验证方法和SNP质控措施。
  • 近期研究提示很大一部分SNP研究不可重复,SNP在急性疾病中的最终临床价值取决于验证与质控措施。

适用人群与场景

  • 急性疾病患者,包括创伤和脓毒症研究人群。

研究设计与关键结果

  • 研究类型为综述;作者于2018年12月和2019年1月检索2011年1月至2019年2月发表的同行评议文献,纳入报告SNP与临床结局关联及SNP与药物(药物基因组学)关联的研究。
  • 以创伤和脓毒症等临床与药物基因关联研究为例,综述当前SNP关联研究的关键方法与结果。
  • 综述发现三点可提高SNP关联研究潜在准确性的要点:提供遵循质控方案的证据、纳入足够患者形成大队列、用独立技术验证SNP。
  • 作者认为需标准化验证方法和SNP质控措施,尤其是在急性疾病等复杂疾病状态下。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,评估急性疾病SNP关联研究时,应关注其是否提供遵循质控方案的证据、是否纳入足够患者形成大队列、是否用独立技术验证SNP。
  • 作者认为需在医学领域、尤其是急性疾病等复杂疾病状态下标准化验证方法和SNP质控措施。

指南或共识出处

  • Nature Protocols
  • OncoArray QC Guidelines

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Acute illness is a complex constellation of responses involving dysregulated inflammatory and immune responses, which are ultimately associated with multiple organ dysfunction. Gene association studies have associated single-nucleotide polymorphisms (SNPs) with clinical and pharmacological outcomes in a variety of disease states, including acute illness. With approximately 4 to 5 million SNPs in the human genome and recent studies suggesting that a large portion of SNP studies are not reproducible, we suggest that the ultimate clinical utility of SNPs in acute illness depends on validation and quality control measures. To investigate this issue, in December 2018 and January 2019 we searched the literature for peer-reviewed studies reporting data on associations between SNPs and clinical outcomes and between SNPs and pharmaceuticals (i.e., pharmacogenomics) published between January 2011 to February 2019. We review key methodologies and results from a variety of clinical and pharmacological gene association studies, including trauma and sepsis studies, as illustrative examples on current SNP association studies. In this review article, we have found three key points which strengthen the potential accuracy of SNP association studies in acute illness and other diseases: providing evidence of following a protocol quality control method such as the one in Nature Protocols or the OncoArray QC Guidelines; enrolling enough patients to have large cohort groups; and validating the SNPs using an independent technique such as a second study using the same SNPs with new patient cohorts. Our survey suggests the need to standardize validation methods and SNP quality control measures in medicine in general, and specifically in the context of complex disease states such as acute illness.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Cohen M, Lamparello AJ, Schimunek L, et al. Quality Control Measures and Validation in Gene Association Studies: Lessons for Acute Illness. Shock. 2020. PMID: 31365490. doi:10.1097/SHK.0000000000001409

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。